MONTREAL -- (MARKET WIRE) -- May 16, 2007 -- TOPIGEN Pharmaceuticals Inc., a clinical-stage biopharmaceutical company specializing in respiratory diseases, today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present updates on the company’s clinical programs at two upcoming conferences: BioEquity Europe 2007 and Bio VentureForum East 2007.
